Provided by Tiger Fintech (Singapore) Pte. Ltd.

Magenta Therapeutics Inc.

11.19
+0.0000
Volume:- -
Turnover:268.84K
Market Cap:42.24M
PE:-0.61
High:11.19
Open:11.19
Low:11.19
Close:11.19
Loading ...
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2021

Major Issues Report

8-K - Current report
Jul 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 07, 2021

Major Issues Report

8-K - Current report
May 27, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 12, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Dec 23, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Major Issues Report

8-K - Current report